Elementis Stock Earnings Reports

Elementis has materially transformed into a pure-play specialty chemicals company focused on two segments: Personal Care and Coatings. Management highlighted completed and in-flight portfolio moves (Talc sold, Chromium sold earlier, and a conditional sale of the non-core pharmaceutical manufacturing business to ABF expected to close in Q2) and the strategic bolt-on acquisition of Alchemy (personal care rheology modifiers). Financially the group delivered resilient 2025 results despite a soft end-market backdrop: group revenue ~$597.5m (down ~1–2% ccy), adjusted operating profit up 4.6% to $126.7m, adjusted operating margin up 150bps to 21.2%, and adjusted EPS +14.2% to $0.137. Personal Care grew (revenue $224.5m) and margin-expanded to 32.4% while Coatings remained resilient (revenue $373m) with margin at 18.9% despite softer industrial/decorative markets. Management completed cost savings programs (total reported savings of ~$18m in the year plus delivery against a further $10m target, $6m already delivered), increased R&D commitment (targeting ~3% of revenue over two years), and recorded free cash flow of $41m (net debt-to-EBITDA ~1.3x after Alchemy and buyback activity). The Board completed a buyback (~4% of shares) and increased the full-year dividend (+7.5% to $0.043), and expects to return net proceeds from the pharma sale to shareholders on closing while targeting ~1x leverage on an organic basis by end-2026. Operational progress includes a debottlenecking program at the St. Louis site (capacity improvement ~20% since H1) and improved service metrics (On-Time-In-Full halfway to medium-term uplift target). Management’s medium-term targets under the "Elevate Elementis" strategy are mid-single-digit revenue growth, operating margins >23%, >90% three-year operating cash conversion and ROCE (ex-goodwill) >30%. Overall tone: pragmatic confidence—focus shifting from restructuring and disposals to high-margin organic growth, R&D-driven innovation (innovation sales 16.4% in 2025, target 20%), selective bolt-on M&A, service improvements and continued cost discipline.